Pfizer news from FierceBiotech
Founded: 1849
Based: New York
CEO: Jeffrey Kindler
2007 Revenue: $48.4 billion
Description: Pfizer is the world's largest research-based biomedical and pharmaceutical company. Corporate headquarters are located in New York, with major research and development locations in the United States and England. In 2006, Pfizer earned $48.4 billion in revenues and invested $7.6 billion in research and development.
NewsPfizer fails again in late-stage anti-clotting trial
There's more bad news for Pfizer's pipeline. An anti-clotting drug it is developing with Bristol-Myers Read more...
Pfizer cancels NicOx drug trial in Asia
In a blow to NicOx, Pfizer decided not to launch a Phase III program for PF-03187207 in Asia. A phase II study compared PF-03187207 to Pfizer's bestselling drug Xalatan and enrolled 112 Japanese Read more...
Pfizer inks vaccine pact with Cytos
Further bolstering its ambitious vaccine program, Pfizer has teamed up with Cytos Biotechnology to develop, manufacture and commercialize vaccines for a defined number of human diseases. Cytos gains Read more...
Pfizer cuts 180 jobs in Ireland
There's bad news for Cork, Ireland today. After an 18-month search, Pfizer announced plans to cut 180 jobs after failing to find a buyer for five manufacturing facilities there. In a statement, the Read more...
Pfizer moves employees to San Francisco
In a major coup for San Francisco, Pfizer is moving 100 employees--along with the headquarters of its Biotherapeutics and Bioinnovation Read more...
Pharma giants to collaborate on new discovery tech
Three of the biggest pharma companies on the planet are joining forces to back an unusual venture aimed at developing "breakthrough" discovery technology that can reduce the frequency of trial Read more...
Pfizer bankrolls a stem cell start-up
Pfizer is bankrolling a biotech start-up that will concentrate on developing new stem cell therapies for eye disease. Scripps Research Institute's Martin Friedlander has undertaken animal studies Read more...
Report: Pfizer makes counter-offer for Ranbaxy
Pfizer may be crashing Daiichi Sankyo's party. Business Standard is reporting that Pfizer is considering a counter-offer for Ranbaxy, India's largest drugmaker. The rumor comes on the heels of the Read more...
Pfizer blazes new research path
Taking a page from the biotech playbook, Pfizer has just inked a three-year, $9.5 million research collaboration pact with the University of California, San Francisco. The money will be used to fund Read more...
| Press ReleasesPfizerAnnounces Discontinuation of Phase III Clinical Trial for Patients with Advanced Melanoma Pfizer Inc. (PFE) Announces Discontinuation of Phase III Clinical Trial for Patients with Advanced Melanoma 4/2/2008 NEW YORK--(BUSINESS WIRE)--Pfizer Inc announced today the discontinuation of a Read more... Tacere Therapeutics Enters Collaboration and License Agreement With Pfizer Tacere Therapeutics Enters Collaboration and License Agreement With Pfizer SAN JOSE, Calif., Jan 07, 2008 -- Tacere Therapeutics, Inc., an RNA interference (RNAi)-based therapeutics developer, Read more... Pfizer and Taisho Pharmaceutical Finalize Deal on Schizophrenia Drug; Pfizer to Pay Initial $22M Pfizer and Taisho Pharmaceutical Finalize Deal on Schizophrenia Drug; Pfizer to Pay Initial $22M NEW YORK & TOKYO--(BUSINESS WIRE)--Pfizer Inc [Headquarter: New York, NY, USA, CEO: Jeffrey B. Read more... PRESS RELEASE: Pfizer to Acquire CovX to Extend Biotherapeutics Investment Pfizer to Acquire CovX to Extend Biotherapeutics Investment Acquisition Will Provide Innovative Biotherapeutics Technology Platform and Complementary Product Candidates in Oncology and Diabetes NEW Read more... PRESS RELEASE: Pfizer and Adolor Enter into Exclusive Worldwide Collaboration to Develop and Commercialize Novel Pain Compounds Pfizer and Adolor Enter into Exclusive Worldwide Collaboration to Develop and Commercialize Novel Pain Compounds NEW YORK & EXTON, Pa. -- Dec 5, 2007 - Pfizer and Adolor Corporation announced Read more... |
Get more Pfizer coverage at:
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets